란투스(Lantus) 시장 : 연령층별, 강도별, 제형별, 최종사용자별, 유통 채널별, 지역별

Lantus Market is estimated to be valued at USD 2.11 Bn in 2025 and is expected to reach USD 3.14 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.84% from 2025 to 2032.

The global Lantus market represents a critical segment within the diabetes therapeutics landscape, focusing on long-acting insulin formulations designed to provide sustained glycemic control for patients with Type 1 and Type 2 diabetes mellitus. Lantus (insulin glargine) is a synthetic, long-acting basal insulin analog that mimics the body's natural insulin production pattern, offering 24-hour glucose control with once-daily dosing. This market encompasses various formulations including vials, pre-filled pens, catering to diverse patient preferences and healthcare delivery systems globally. The market's significance stems from the growing prevalence of diabetes worldwide, affecting over 537 million adults globally, with projections indicating substantial increases in the coming decades. Technological advancements in insulin delivery systems, coupled with improved patient compliance and outcomes, have positioned Lantus as a cornerstone therapy in diabetes management protocols. The market dynamics are influenced by factors including patent expirations, biosimilar competition, regulatory frameworks, healthcare infrastructure development, and evolving treatment guidelines that emphasize personalized diabetes care approaches for optimal patient outcomes.

Market Dynamics

The global Lantus market is propelled by several key drivers that continue to shape its growth trajectory, with the primary catalyst being the escalating global diabetes epidemic, particularly Type 2 diabetes, driven by sedentary lifestyles, dietary changes, and increasing obesity rates across developed and emerging economies. The superior pharmacokinetic profile of Lantus, offering peak less insulin action and reduced hypoglycemic episodes compared to conventional insulin formulations, drives physician preference and patient adoption, while continuous innovation in delivery mechanisms including smart insulin pens and connected devices enhances treatment adherence and monitoring capabilities. However, the market faces significant restraints including patent cliff challenges that have opened doors for biosimilar competition, substantially impacting pricing strategies and market share dynamics, while stringent regulatory approval processes for new formulations and delivery systems create barriers to market entry and expansion. Additionally, healthcare cost containment pressures, particularly in developed markets, along with complex reimbursement landscapes and varying insurance coverage policies, limit market accessibility and growth potential. Despite these challenges, substantial opportunities emerge from expanding healthcare infrastructure in emerging markets across Asia-Pacific, Latin America, and Africa, where diabetes prevalence is rising rapidly but treatment penetration remains low, creating untapped market potential. The integration of digital health technologies, including continuous glucose monitoring systems and artificial intelligence-driven diabetes management platforms, presents opportunities for enhanced patient outcomes and market differentiation, while growing awareness about diabetes complications and the importance of glycemic control drives demand for premium insulin therapies like Lantus in both developed and developing healthcare systems.

Key Features of the Study

• This report provides in-depth analysis of the global Lantus market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global Lantus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key company covered as a part of this study include Sanofi.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global Lantus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Lantus market.

Market Segmentation

• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Pediatric
  • Adult
• Strength Insights (Revenue, USD Bn, 2020 - 2032)
  • 10 mL
  • 3 mL
• Dosage Form Insights (Revenue, USD Bn, 2020 - 2032)
  • Multi-dose Vial
  • Single Patient use Prefilled pen
• End User Insights (Revenue, USD, 2020 - 2032)
  • Hospitals
  • Specialty Clinics
  • Long-Term Care Facilities
  • Others (Home Care Settings, etc.)
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Sanofi

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Lantus Market, By Age Group
  • Global Lantus Market, By Strength
  • Global Lantus Market, By Dosage Form
  • Global Lantus Market, By End User
  • Global Lantus Market, By Distribution Channel
  • Global Lantus Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trends
• Epidemiology
• Treatment Option Analysis
• Price Differentiation Analysis (Lantus and Biosimilars)
• Reimbursement Scenario
• Adherence and Switch Rate Analysis in U.S.
• Disease Awareness Programs

4. Global Lantus Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Lantus Market, By Strength, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• 10 mL
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 3 mL
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Lantus Market, By Dosage Form, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Multi-dose Vial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Single Patient use Prefilled pen
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Lantus Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Long-Term Care Facilities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Home Care Settings, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Lantus Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Lantus Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us